Search research articles
Contact Us
Filters
Showing results (451-460 of 489) with videos related to
Page
of 49
Sort By:
Journal of the American College of Cardiology
|
April 4, 2006
Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain
W Patricia Ingkanisorn, Raymond Y Kwong, Nicole S Bohme, et al.
Antimicrobial Agents and Chemotherapy
|
September 19, 2012
Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers
Susan E Puckett, Kaleb A Reese, Georgi M Mitev, et al.
Pharmacogenomics
|
October 8, 2004
Rationale and study design of the CardioGene Study: genomics of in-stent restenosis
Santhi K Ganesh, Kimberly A Skelding, Laxmi Mehta, et al.
Circulation
|
June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators
L Campeau, D B Hunninghake, G L Knatterud, et al.
The American Journal of Cardiology
|
March 4, 2008
Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function
Judith Hsia, Kathleen A Jablonski, Madeline Murguia Rice, et al.
Infection and Immunity
|
August 19, 2015
Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease
David E Greenberg, Daniel E Sturdevant, Kimberly R Marshall-Batty, et al.
Circulation
|
July 13, 2000
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators
G L Knatterud, Y Rosenberg, L Campeau, et al.
European Heart Journal
|
March 17, 2012
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
Faiez Zannad, Wendy Gattis Stough, Stuart J Pocock, et al.
Circulation
|
November 28, 2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial
C W White, F L Gobel, L Campeau, et al.
Journal of Clinical Gastroenterology
|
December 13, 2005
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease
Maria T Abreu, Jordan L Geller, Eric A Vasiliauskas, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 489) with videos related to
Sort By:
Page
of 49
Journal of the American College of Cardiology
|
April 4, 2006
Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain
W Patricia Ingkanisorn, Raymond Y Kwong, Nicole S Bohme, et al.
Antimicrobial Agents and Chemotherapy
|
September 19, 2012
Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers
Susan E Puckett, Kaleb A Reese, Georgi M Mitev, et al.
Pharmacogenomics
|
October 8, 2004
Rationale and study design of the CardioGene Study: genomics of in-stent restenosis
Santhi K Ganesh, Kimberly A Skelding, Laxmi Mehta, et al.
Circulation
|
June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators
L Campeau, D B Hunninghake, G L Knatterud, et al.
The American Journal of Cardiology
|
March 4, 2008
Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function
Judith Hsia, Kathleen A Jablonski, Madeline Murguia Rice, et al.
Infection and Immunity
|
August 19, 2015
Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease
David E Greenberg, Daniel E Sturdevant, Kimberly R Marshall-Batty, et al.
Circulation
|
July 13, 2000
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators
G L Knatterud, Y Rosenberg, L Campeau, et al.
European Heart Journal
|
March 17, 2012
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
Faiez Zannad, Wendy Gattis Stough, Stuart J Pocock, et al.
Circulation
|
November 28, 2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial
C W White, F L Gobel, L Campeau, et al.
Journal of Clinical Gastroenterology
|
December 13, 2005
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease
Maria T Abreu, Jordan L Geller, Eric A Vasiliauskas, et al.
Page
of 49